Newsletter Archive
-
01.20.21 -- Pitching And Fundraising In The New Norm
1/20/2021
01/20/21 Life Science Leader Newsletter
-
01.20.21 -- How High-Throughput Formulation Development Impacts Early Screening Studies
1/20/2021
01/20/21 Life Science Leader Newsletter
-
01.19.21 -- Overcoming Cell And Gene Commercialization Challenges
1/19/2021
01/19/21 Life Science Leader Newsletter
-
01.18.21 -- What I Learned Running A Biotech During The Pandemic
1/18/2021
01/18/21 Life Science Leader Newsletter
-
01.18.21 -- How To Create A Connected mAb Perfusion Process
1/18/2021
01/18/21 Life Science Leader Newsletter
-
01.15.21 -- FDA FY2020 Drug Inspection Observations And Trends
1/15/2021
01/15/21 Life Science Leader Newsletter
-
01.15.21 -- How To Navigate Regulatory Frameworks For Gene Therapy Development
1/15/2021
01/15/21 Life Science Leader Newsletter
-
01.14.21 -- Reducing Risk In Transferring Vaccine Production
1/14/2021
01/14/21 Life Science Leader Newsletter
-
01.13.21 -- Going Public In Mid-Pandemic
1/13/2021
01/13/21 Life Science Leader Newsletter
-
01.13.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale
1/13/2021
01/13/21 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more